Edwards Lifesciences Corp. unveiled a new option in its heart valve franchise on Tuesday. The Irvine-based valve maker’s Ascendra procedure uses an aortic heart valve replacement system that is less ...

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...

An analyst earlier this month took aim at what’s behind a big run-up in shares of Irvine medical device maker Edwards Lifesciences Corp.: a new type of heart valve that doesn’t require major surgery.

The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study ...

TORONTO, ON -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that three-year clinical outcomes of its EDWARDS INTUITY ...

NEW ORLEANS, April 3 (Reuters) - A heart valve replacement technique developed by Edwards LifeSciences Corp <EW.N> that spares patients open-heart surgery had a slightly lower death rate at one year, ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.

Edwards Lifesciences (NYSE:EW) develops medical devices for structural heart disease, transcatheter procedures, and critical care, highlighting operational performance in the NYSE Composite sector.

CHICAGO (Reuters) - Edwards LifeSciences Corp's less-invasive replacement heart valve alleviates symptoms such as fatigue and breathlessness better than standard medical therapy, data released on ...

Edwards Lifesciences guidance update highlights structural heart technology activity within the s&p 500, covering earnings ...